Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Factitious biochemical measurements resulting from hematologic conditions.

Dalal BI, Brigden ML.

Am J Clin Pathol. 2009 Feb;131(2):195-204. doi: 10.1309/AJCPY9RP5QYTYFWC. Review.

PMID:
19141380
2.
3.

Artifacts that may be present on a blood film.

Dalal BI, Brigden ML.

Clin Lab Med. 2002 Mar;22(1):81-100, vi. Review.

PMID:
11933583
5.

Detection, education and management of the asplenic or hyposplenic patient.

Brigden ML.

Am Fam Physician. 2001 Feb 1;63(3):499-506, 508. Review.

6.

Hematologic and oncologic emergencies. Doing the most good in the least time.

Brigden ML.

Postgrad Med. 2001 Mar;109(3):143-6, 151-4, 157-8 passim. Review.

PMID:
11265352
8.
10.

Problems in interpreting laboratory tests. What do unexpected results mean?

Brigden ML, Heathcote JC.

Postgrad Med. 2000 Jun;107(7):145-6, 151-2, 155-8 passim. Review.

PMID:
10887452
11.

Schilling test still useful in pernicious anemia?

Brigden ML.

Postgrad Med. 1999 Oct 15;106(5):37-8. No abstract available.

PMID:
10560466
12.

Clinical utility of the erythrocyte sedimentation rate.

Brigden ML.

Am Fam Physician. 1999 Oct 1;60(5):1443-50.

13.
14.
15.

Improving survival in metastatic carcinoma of unknown origin.

Brigden ML, Murray N.

Postgrad Med. 1999 May 1;105(5):63-4, 67-74. Review.

PMID:
10335321
16.

Prevention and management of overwhelming postsplenectomy infection--an update.

Brigden ML, Pattullo AL.

Crit Care Med. 1999 Apr;27(4):836-42. Review.

PMID:
10321679
17.

A practical workup for eosinophilia. You can investigate the most likely causes right in your office.

Brigden ML.

Postgrad Med. 1999 Mar;105(3):193-4, 199-202, 207-10. Review.

PMID:
10086043
18.

Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population.

Brigden ML, Kay C, Le A, Graydon C, McLeod B.

Am J Hematol. 1998 Sep;59(1):22-7.

19.

INR reporting in Canadian medical laboratories: an update. Thrombosis Interest Group of Canada.

Brigden ML, Johnston MJ.

Am J Clin Pathol. 1998 May;109(5):589-94.

PMID:
9576578
20.

Prothrombin time determination. The lack of need for a discard tube and 24-hour stability.

Brigden ML, Graydon C, McLeod B, Lesperance M.

Am J Clin Pathol. 1997 Oct;108(4):422-6.

PMID:
9322596
21.

The hypercoagulable state. Who, how, and when to test and treat.

Brigden ML.

Postgrad Med. 1997 May;101(5):249-52, 254-6, 259-62 passim. Review.

PMID:
9158617
22.

Advances in anticoagulation.

Brigden ML.

Postgrad Med. 1996 Jun;99(6):57-58. doi: 10.1080/00325481.1996.11946136. No abstract available.

PMID:
29206591
23.

Oral anticoagulant therapy.

Brigden ML.

Postgrad Med. 1996 Jun;99(6):81-102. doi: 10.1080/00325481.1996.11946138.

PMID:
29206589
24.

The anti-phospholipid syndrome.

Devine DV, Brigden ML.

Postgrad Med. 1996 Jun;99(6):105-125. doi: 10.1080/00325481.1996.11946139.

PMID:
29206588
25.

Oral anticoagulant therapy: practical aspects of management.

Brigden ML.

Postgrad Med. 1996 Jun;99(6):81-4, 87-9, 93-4 passim. Review.

PMID:
8668640
26.

The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy?

Devine DV, Brigden ML.

Postgrad Med. 1996 Jun;99(6):105-8, 113-25. Review.

PMID:
8668625
27.

Unproven (questionable) cancer therapies.

Brigden ML.

West J Med. 1995 Nov;163(5):463-9. Review.

28.

When bleeding complicates oral anticoagulant therapy.

Brigden ML.

Postgrad Med. 1995 Sep;98(3):153-168. doi: 10.1080/00325481.1995.11946049.

PMID:
29231102
29.

When bleeding complicates oral anticoagulant therapy. How to anticipate, investigate, and treat.

Brigden ML.

Postgrad Med. 1995 Sep;98(3):153-4, 159-62, 164-5, passim. Review.

PMID:
7675740
30.

A systematic approach to macrocytosis.

Brigden ML.

Postgrad Med. 1995 May;97(5):171-186. doi: 10.1080/00325481.1995.11945999.

PMID:
29211645
31.

A systematic approach to macrocytosis. Sorting out the causes.

Brigden ML.

Postgrad Med. 1995 May;97(5):171-2, 175-7, 181-4 passim.

PMID:
7753741
32.

Clinically appropriate investigations in cases of suspected lupus anticoagulant.

Brigden ML, Ferguson DJ.

Am J Clin Pathol. 1995 Mar;103(3):376. No abstract available.

PMID:
7872265
33.

Evaluation of the Sysmex NE-8000. Automated hematology analyzer in a high-volume outpatient laboratory.

Brigden ML, Page NE, Graydon C.

Am J Clin Pathol. 1993 Dec;100(6):618-25.

PMID:
8249908
34.

Macrophage-tumor cell associations: a factor in metastasis of breast cancer?

van Netten JP, Ashmead BJ, Parker RL, Thornton IG, Fletcher C, Cavers D, Coy P, Brigden ML.

J Leukoc Biol. 1993 Oct;54(4):360-2.

PMID:
8409759
35.

Overwhelming postsplenectomy infection.

Brigden ML.

West J Med. 1993 Mar;158(3):308-9. No abstract available.

36.

Iron deficiency anemia. Every case is instructive.

Brigden ML.

Postgrad Med. 1993 Mar;93(4):181-2, 185-92.

PMID:
8446533
37.

Overwhelming postsplenectomy infection still a problem.

Brigden ML.

West J Med. 1992 Oct;157(4):440-3. Review.

38.

'Macrophages' and their putative significance in human breast cancer.

van Netten JP, Ashmed BJ, Cavers D, Fletcher C, Thornton IG, Antonsen BL, Coy P, Brigden ML.

Br J Cancer. 1992 Jul;66(1):220-1. No abstract available.

39.
40.

Oral anticoagulant therapy. Newer indications and an improved method of monitoring.

Brigden ML.

Postgrad Med. 1992 Feb 1;91(2):285-8, 293-6. Review.

PMID:
1738747
41.

The relationship between the absolute granulocyte count, platelet count and total leukocyte count in cancer chemotherapy patients.

Brigden ML, Mawji KB, Wilson KS, Spinelli JJ.

Clin Invest Med. 1991 Oct;14(5):395-401.

PMID:
1742917
42.

Evaluation of the Cell-Dyn 1600 in an outpatient laboratory.

Page NE, Brigden ML.

Clin Lab Sci. 1991 Jul-Aug;4(4):242-5.

PMID:
10149425
43.

The clinical utility of serum tests for iron deficiency in hospitalized patients.

Brigden ML.

Am J Clin Pathol. 1990 Aug;94(2):245. No abstract available.

PMID:
2242139
44.

Alert for eosinophilia-myalgia syndrome.

Brigden ML, Martin JM, Ghesquiere WG, Stevens DC.

Can Fam Physician. 1990 May;36:850-2. No abstract available.

45.

The optimum urine collections for the detection and monitoring of Bence Jones proteinuria.

Brigden ML, Neal ED, McNeely MD, Hoag GN.

Am J Clin Pathol. 1990 May;93(5):689-93.

PMID:
2327368
47.

An apparatus to retain the spatial orientation of breast biopsies.

van Netten JP, Racca RL, Armstrong JB, Brigden ML, Sellers AR, Coy P, Fletcher C, Thornton IG.

Anal Cell Pathol. 1989 Dec;2(1):59-62.

PMID:
2486911
48.

Cellular distribution patterns of estrogen receptor in human breast cancer.

van Netten JP, Armstrong JB, Carlyle SJ, Goodchild NL, Thornton IG, Brigden ML, Coy P, Fletcher C.

Eur J Cancer Clin Oncol. 1988 Dec;24(12):1899-901. No abstract available.

PMID:
3220086
49.

Estrogen receptor distribution in the peripheral, intermediate and central regions of breast cancers.

van Netten JP, Armstrong JB, Carlyle SS, Goodchild NL, Thornton IG, Brigden ML, Coy P, Fletcher C.

Eur J Cancer Clin Oncol. 1988 Dec;24(12):1885-9.

PMID:
3220085
50.

Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy.

Osoba D, Erlichman C, Willan AR, Brigden ML, Geggie P, Pater JL, Rusthoven JJ, Wilson KS.

Clin Invest Med. 1988 Oct;11(5):377-9.

PMID:
3052974

Supplemental Content

Loading ...
Support Center